Hubei Goto Biopharm Statistics

Total Valuation

SHE:300966 has a market cap or net worth of CNY 1.80 billion. The enterprise value is 2.88 billion.

Market Cap	1.80B
Enterprise Value	2.88B

Important Dates

The last earnings date was Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300966 has 115.28 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class	n/a
Shares Outstanding	115.28M
Shares Change (YoY)	-0.05%
Shares Change (QoQ)	+7.82%
Owned by Insiders (%)	44.66%
Owned by Institutions (%)	3.33%
Float	54.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.35
PB Ratio	1.77
P/TBV Ratio	2.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 69.93, with an EV/FCF ratio of -8.66.

EV / Earnings	-104.31
EV / Sales	5.36
EV / EBITDA	69.93
EV / EBIT	n/a
EV / FCF	-8.66

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.12.

Current Ratio	0.95
Quick Ratio	0.44
Debt / Equity	1.12
Debt / EBITDA	27.49
Debt / FCF	-3.41
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.11% and return on invested capital (ROIC) is -0.07%.

Return on Equity (ROE)	-3.11%
Return on Assets (ROA)	-0.05%
Return on Invested Capital (ROIC)	-0.07%
Return on Capital Employed (ROCE)	-0.11%
Revenue Per Employee	850,389
Profits Per Employee	-43,726
Employee Count	631
Asset Turnover	0.20
Inventory Turnover	1.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.42% in the last 52 weeks. The beta is 0.12, so SHE:300966's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+5.42%
50-Day Moving Average	16.49
200-Day Moving Average	16.70
Relative Strength Index (RSI)	46.53
Average Volume (20 Days)	2,771,723

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300966 had revenue of CNY 536.60 million and -27.59 million in losses. Loss per share was -0.24.

Revenue	536.60M
Gross Profit	105.56M
Operating Income	-2.09M
Pretax Income	-45.54M
Net Income	-27.59M
EBITDA	40.89M
EBIT	-2.09M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 141.18 million in cash and 1.13 billion in debt, giving a net cash position of -990.37 million or -8.59 per share.

Cash & Cash Equivalents	141.18M
Total Debt	1.13B
Net Cash	-990.37M
Net Cash Per Share	-8.59
Equity (Book Value)	1.01B
Book Value Per Share	8.73
Working Capital	-37.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.59 million and capital expenditures -311.61 million, giving a free cash flow of -332.20 million.

Operating Cash Flow	-20.59M
Capital Expenditures	-311.61M
Free Cash Flow	-332.20M
FCF Per Share	-2.88

Full Cash Flow Statement

Margins

Gross margin is 19.67%, with operating and profit margins of -0.39% and -5.14%.

Gross Margin	19.67%
Operating Margin	-0.39%
Pretax Margin	-8.49%
Profit Margin	-5.14%
EBITDA Margin	7.62%
EBIT Margin	-0.39%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.10%.

Dividend Per Share	0.02
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.05%
Shareholder Yield	0.16%
Earnings Yield	-1.54%
FCF Yield	-18.50%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a